Literature DB >> 18398143

Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens?

Carsten Bokemeyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18398143     DOI： 10.1200/JCO.2007.15.2991

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Bleomycin lung: a case report.

Authors:  Rabia Sofia Rashid
Journal:  BMJ Case Rep       Date:  2009-04-14

Review 2.  Standard versus high-dose chemotherapy in mediastinal germ cell tumors: a narrative review.

Authors:  Emilio Francesco Giunta; Margaret Ottaviano; Alessandra Mosca; Giuseppe Luigi Banna; Pasquale Rescigno
Journal:  Mediastinum       Date:  2022-03-25

Review 3.  [Systemic treatment of advanced colorectal cancer].

Authors:  A Reinacher-Schick
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

4.  Resistance to bleomycin in cancer cell lines is characterized by prolonged doubling time, reduced DNA damage and evasion of G2/M arrest and apoptosis.

Authors:  Qi Wang; Kangping Cui; Osvaldo Espin-Garcia; Dangxiao Cheng; Xiaoping Qiu; Zhuo Chen; Malcolm Moore; Robert G Bristow; Wei Xu; Sandy Der; Geoffrey Liu
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.